Seeing Is Believing
Currently out of the existing stock ratings of David Lewis, 69 are a BUY (57.5%), 46 are a HOLD (38.33%), 5 are a SELL (4.17%).
Analyst David Lewis works with a stock forecast success ratio of 82.81% fulfilled within 255.39 days on average. Previously, David Lewis worked at MORGAN STANLEY.
David Lewis’s has documented 311 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AXNX, Axonics Modulation Technologies at 31-Oct-2023.
Analyst best performing recommendations are on SWAV (SHOCKWAVE MEDICAL).
The best stock recommendation documented was for SWAV (SHOCKWAVE MEDICAL) at 4/1/2019. The price target of $32 was fulfilled within 2 days with a profit of $1.53 (4.56%) receiving and performance score of 22.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
388
$6.98 (1.83%)
355
1 years 5 months 23 days ago
2/5 (40%)
$14.49 (3.88%)
88
Hold
380
$-1.02 (-0.27%)
235
1 years 5 months 23 days ago
1/2 (50%)
$6.49 (1.74%)
36
Hold
380
$-1.02 (-0.27%)
350
1 years 5 months 24 days ago
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
300
$-81.02 (-21.26%)
425
1 years 6 months 13 days ago
1/2 (50%)
$57.23 (23.57%)
20
Sell
235
$-146.02 (-38.32%)
275
1 years 9 months 10 days ago
6/8 (75%)
$-33.23 (-12.39%)
142
Which stock is David Lewis is most bullish on?
What Year was the first public recommendation made by David Lewis?